首頁 > 市場調查報告書 > 醫療設備

導管心血管設備

市場調查報告書

商品編碼

2126154

2026-2030年全球經導管主動脈瓣置換術術市場

Global Transcatheter Aortic Valve Replacement Market 2026-2030

出版日期: 2026年09月03日 | 出版商:

TechNavio | 英文 302 Pages | 訂單完成後即時交付

價格

簡介目錄

全球經導管主動脈瓣置換術(TAVR) 市場預計將從 2025 年到 2030 年成長至 28.621 億美元，預測期內複合年成長率為 7.1%。

這份關於全球經導管主動脈瓣置換術(TAVR) 市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括心血管疾病盛行率上升、全球人口老化、瓣膜設計和輸送系統的技術進步以及微創手術日益普及。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模資料、細分市場資訊（包括區域分析）以及供應商格局。報告包含歷史數據和預測數據。

市場範圍
基準年	2025
年末	2030
調查期	2026-2030
成長勢頭	加速度
2026 年同比比較	6.7%
複合年成長率	7.1%
增量	28.621億美元

本研究指出，人工智慧和先進的預測影像技術在術前規劃的應用，將是未來幾年全球經導管主動脈瓣置換術（TAVR）市場成長的關鍵促進因素。此外，終身管理策略、對「瓣膜內」治療的重視以及中度主動脈瓣狹窄和無症狀病例臨床適應症的擴大，預計也將帶來顯著的市場需求。

區域細分
區域比較
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
亞洲
- 日本
- 中國
- 韓國
- 印度
- 印尼
- 泰國
世界其他地區（RoW）
- 巴西
- 沙烏地阿拉伯
- 土耳其
- UAE
- 阿根廷
- 南非
- 哥倫比亞
- 以色列
市場機會：按地區分類

第13章促進因素、挑戰與機遇

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機遇

第14章競爭格局

概述
競爭格局
混亂局面
產業風險

第15章競爭分析

公司簡介
公司排名指標
企業市場定位
Abbott Laboratories
Boston Scientific Corp.
Edwards Lifesciences Corp.
Genesis Medtech International
Lepu Medical Co. Ltd.
Lifetech Scientific Corp.
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
MicroPort Scientific Corp.
Peijia Medical Ltd.
Sichuan Mark Hi-Tech Co. Ltd.
Sino Medical Sciences Technology
Thubrikar Aortic Valve Inc.
Venus Medtech Hangzhou Inc.
Xeltis AG

第16章附錄

簡介目錄

Product Code: IRTNTR76453

The global transcatheter aortic valve replacement market is forecasted to grow by USD 2862.1 mn during 2025-2030, accelerating at a CAGR of 7.1% during the forecast period. The report on the global transcatheter aortic valve replacement market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiovascular diseases and an aging global population, technological advancements in valve design and delivery systems, increasing preference for minimally invasive surgical procedures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	6.7%
CAGR	7.1%
Incremental Value	$2862.1 mn

Technavio's global transcatheter aortic valve replacement market is segmented as below:

By End-User

Hospitals
Ambulatory surgical centers
Others

By Type

Balloon-expanding valve
Self expanding valve

By Technique

Transfemoral approach
Transapical approach
Transaortic approach
Others

Geography

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
Asia
Rest of World (ROW)
Rest of World (ROW)

This study identifies the integration of ai and advanced predictive imaging in preprocedural planning as one of the prime reasons driving the global transcatheter aortic valve replacement market growth during the next few years. Also, emphasis on lifetime management strategies and valve in valve interventions and clinical expansion into moderate aortic stenosis and asymptomatic patient populations will lead to sizable demand in the market.

The report on the global transcatheter aortic valve replacement market covers the following areas:

Global transcatheter aortic valve replacement market sizing
Global transcatheter aortic valve replacement market forecast
Global transcatheter aortic valve replacement market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global transcatheter aortic valve replacement market vendors that include Abbott Laboratories, Anteris Technologies Ltd., Boston Scientific Corp., Colibri Heart Valve LLC, Edwards Lifesciences Corp., Foldax Inc., Genesis Medtech International, Hangzhou Valgen Medtech Co. Ltd., Hanyu Medical, Lepu Medical Co. Ltd., Lifetech Scientific Corp., Medtronic Plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corp., Peijia Medical Ltd., Sichuan Mark Hi-Tech Co. Ltd., Sino Medical Sciences Technology, Thubrikar Aortic Valve Inc., Venus Medtech Hangzhou Inc., Xeltis AG. Also, the global transcatheter aortic valve replacement market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Technique
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Global Transcatheter Aortic Valve Replacement Market 2020 - 2024
- Historic Market Size - Data Table on Global Transcatheter Aortic Valve Replacement Market 2020 - 2024 ($ million)
5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
5.4 Technique segment analysis 2020 - 2024
- Historic Market Size - Technique Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on global transcatheter aortic valve replacement market
6.2 Impact of geopolitical conflicts on global transcatheter aortic valve replacement market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition

8 Market Segmentation by End-user

8.1 Market segments
8.2 Comparison by End-user
8.3 Hospitals - Market size and forecast 2025-2030
8.4 Ambulatory surgical centers - Market size and forecast 2025-2030
8.5 Others - Market size and forecast 2025-2030
8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)

9 Market Segmentation by Type

9.1 Market segments
9.2 Comparison by Type
9.3 Balloon-expanding valve - Market size and forecast 2025-2030
9.4 Self expanding valve - Market size and forecast 2025-2030
9.5 Market opportunity by Type
- Market opportunity by Type ($ million)

10 Market Segmentation by Technique

10.1 Market segments
10.2 Comparison by Technique
10.3 Transfemoral approach - Market size and forecast 2025-2030
10.4 Transapical approach - Market size and forecast 2025-2030
10.5 Transaortic approach - Market size and forecast 2025-2030
10.6 Others - Market size and forecast 2025-2030
10.7 Market opportunity by Technique
- Market opportunity by Technique ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
12.2 Geographic comparison
12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 Japan - Market size and forecast 2025-2030
- 12.5.2 China - Market size and forecast 2025-2030
- 12.5.3 South Korea - Market size and forecast 2025-2030
- 12.5.4 India - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 Turkey - Market size and forecast 2025-2030
- 12.6.4 UAE - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 South Africa - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Rising prevalence of cardiovascular diseases and an aging global population
- Technological advancements in valve design and delivery systems
- Increasing preference for minimally invasive surgical procedures
13.2 Market challenges
- High financial burden and inequitable reimbursement frameworks
- Stringent regulatory landscapes and prolonged clinical validation requirements
- Steep learning curve and shortage of specialized cardiovascular personnel
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Integration of AI and advanced predictive imaging in preprocedural planning
- Emphasis on lifetime management strategies and valve in valve interventions
- Clinical expansion into moderate aortic stenosis and asymptomatic patient populations

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
15.5 Boston Scientific Corp.
- Boston Scientific Corp. - Overview
- Boston Scientific Corp. - Business segments
- Boston Scientific Corp. - Key offerings
- Boston Scientific Corp. - Segment focus
- SWOT
15.6 Edwards Lifesciences Corp.
- Edwards Lifesciences Corp. - Overview
- Edwards Lifesciences Corp. - Business segments
- Edwards Lifesciences Corp. - Key news
- Edwards Lifesciences Corp. - Key offerings
- Edwards Lifesciences Corp. - Segment focus
- SWOT
15.7 Genesis Medtech International
- Genesis Medtech International - Overview
- Genesis Medtech International - Product / Service
- Genesis Medtech International - Key offerings
- SWOT
15.8 Lepu Medical Co. Ltd.
- Lepu Medical Co. Ltd. - Overview
- Lepu Medical Co. Ltd. - Product / Service
- Lepu Medical Co. Ltd. - Key offerings
- SWOT
15.9 Lifetech Scientific Corp.
- Lifetech Scientific Corp. - Overview
- Lifetech Scientific Corp. - Business segments
- Lifetech Scientific Corp. - Key offerings
- Lifetech Scientific Corp. - Segment focus
- SWOT
15.10 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
15.11 Meril Life Sciences Pvt. Ltd.
- Meril Life Sciences Pvt. Ltd. - Overview
- Meril Life Sciences Pvt. Ltd. - Product / Service
- Meril Life Sciences Pvt. Ltd. - Key offerings
- SWOT
15.12 MicroPort Scientific Corp.
- MicroPort Scientific Corp. - Overview
- MicroPort Scientific Corp. - Business segments
- MicroPort Scientific Corp. - Key offerings
- MicroPort Scientific Corp. - Segment focus
- SWOT
15.13 Peijia Medical Ltd.
- Peijia Medical Ltd. - Overview
- Peijia Medical Ltd. - Business segments
- Peijia Medical Ltd. - Key offerings
- Peijia Medical Ltd. - Segment focus
- SWOT
15.14 Sichuan Mark Hi-Tech Co. Ltd.
- Sichuan Mark Hi-Tech Co. Ltd. - Overview
- Sichuan Mark Hi-Tech Co. Ltd. - Product / Service
- Sichuan Mark Hi-Tech Co. Ltd. - Key offerings
- SWOT
15.15 Sino Medical Sciences Technology
- Sino Medical Sciences Technology - Overview
- Sino Medical Sciences Technology - Product / Service
- Sino Medical Sciences Technology - Key offerings
- SWOT
15.16 Thubrikar Aortic Valve Inc.
- Thubrikar Aortic Valve Inc. - Overview
- Thubrikar Aortic Valve Inc. - Product / Service
- Thubrikar Aortic Valve Inc. - Key offerings
- SWOT
15.17 Venus Medtech Hangzhou Inc.
- Venus Medtech Hangzhou Inc. - Overview
- Venus Medtech Hangzhou Inc. - Product / Service
- Venus Medtech Hangzhou Inc. - Key offerings
- SWOT
15.18 Xeltis AG
- Xeltis AG - Overview
- Xeltis AG - Product / Service
- Xeltis AG - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations